FITC Anti-IL-6R antibody [B-R6]
Be the first to review this product! Submit a review
|
(4 Publications)
Mouse Monoclonal IL-6R antibody - conjugated to FITC. Suitable for Flow Cyt and reacts with Human samples. Cited in 4 publications.
View Alternative Names
CD126, Interleukin-6 receptor subunit alpha, IL-6 receptor subunit alpha, IL-6R subunit alpha, IL-6R-alpha, IL-6RA, IL-6R 1, Membrane glycoprotein 80, gp80, IL6R
- Flow Cyt
Unknown
Flow Cytometry - FITC Anti-IL-6R antibody [B-R6] (AB27321)
ab27321 at 10μl/106 cells staining IL6R in U266 cell line by Flow Cytometry.
This image was generated using the ascites version of the product.
Reactivity data
Product details
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IL-6 receptor function involves mediating the effects of IL-6 through its interaction with glycoprotein 130 (gp130) forming a signaling complex. This complex initiates intracellular pathways that lead to gene expression changes necessary for immune responses inflammation and hematopoiesis. When IL-6 binds IL-6R the complex formation with gp130 triggers downstream signaling that impacts cell growth differentiation and survival.
Pathways
IL-6R is central to the JAK/STAT signaling pathway one of the two main pathways activated by IL-6 signaling. It's also involved in the MAPK cascade contributing to cellular responses such as proliferation and differentiation. Through these pathways IL-6R interacts with other proteins like JAK kinases and STAT transcription factors coordinating cellular responses to external signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 20:339 PubMed33123250
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 20:263 PubMed32989397
2020
Applications
Unspecified application
Species
Unspecified reactive species
Leukemia & lymphoma 59:178-186 PubMed28540748
2017
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells (Dayton, Ohio) 27:2393-404 PubMed19658188
2009
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com